Bon announces identification of promising weight-managing compounds from tea via ai-powered new drug r&d platform

Xi'an, china , sept. 2, 2025 /prnewswire/ -- bon natural life limited (nasdaq: bon) ("bon" or the "company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a groundbreaking identification of a class of natural polyphenolic compounds from a tea-derived product via its ai-powered new drug research and development (r&d) platform.
BON Ratings Summary
BON Quant Ranking